The Oncology Institute · 2 months ago
Hematologist Oncologist Pasadena / Glendale, CA
Pasadena, California, United States
Full-time
Onsite
Senior Level
$600K/yr - $650K/yrThe Oncology Institute is a leader in value-based cancer care, providing specialized services to a large patient population. The role of Hematologist Oncologist involves building relationships with patients, offering clinical trials, and collaborating within a supportive physician team.
Health CareHealth DiagnosticsHome Health CareMedicalOncologyPsychology
Responsibilities
Make a difference in the lives of patients while providing support throughout their care journey
Grow as a leader, pursuing roles such as Medical Director or Principal Investigator within Clinical Research
Work within community-centered clinics with access to Medical Director and extended Physician leadership team for support
Participate in Tumor Boards, case discussions, and ongoing professional education with a collaborative Physician team
Qualification
Required
Board Certified/Board Eligible in Hematology and Oncology
Eligible for medical licensure in California
Preferred
H1B candidates are considered and welcome to apply
Benefits
Attractive base compensation - $650k+, semi-annual wRVU bonus, equity, signing bonus, relocation + comprehensive benefits package, including medical, dental, vision, matching 401k, CME allowance, pet insurance
Company
The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting.
Founded in 2007
501-1000 employees
H1B Sponsorship
The Oncology Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$291.5MKey Investors
Deerfield
2025-03-24Post Ipo Equity· $16.5M
2021-11-15Post Ipo Equity· $275M
2021-11-15IPO
Leadership Team
Daniel Virnich
Board Member
Jeffrey Langsam
Chief Clinical Officer
Recent News
2026-01-11
2026-01-10
2026-01-05
Company data provided by crunchbase